Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Donald E. Wallroth currently holds 37,500 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donald E. Wallroth has been a net seller of MIPI stock. They have purchased $0 and sold $24.6K worth of shares.
Donald E. Wallroth's most recent insider trade was on Sep 28, 2009, when they sold 13,500 shares at $3.93 per share.
Donald E. Wallroth serves as Executive at Molecular Insight Pharmaceuticals, Inc. (MIPI). They have executed 10 insider transactions totaling $24.6K over their tenure at the company.
Donald E. Wallroth holds the position of Executive at Molecular Insight Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Donald E. Wallroth has shown a selling trading pattern, with $0 in total purchases and $24.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Donald E. Wallroth was on Sep 28, 2009, when they sold $53.1K worth of MIPI shares. This transaction involved 13,500 shares at $3.93 per share.
Donald E. Wallroth currently owns 37,500 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Donald E. Wallroth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Donald E. Wallroth has 10 Form 4 filings on record as an insider at Molecular Insight Pharmaceuticals, Inc..
Set alerts for Donald E. Wallroth and 40,000+ other insiders.